Jang-Ho Cha

Role: Chief Scientific Officer at Latus Bio
Location: Cambridge, MA, US
LinkedIn followers: 500 followers

Research & DevelopmentView LinkedIn profile

About Jang-Ho Cha

Neurologist, neuroscientist, with significant experience in academic neurology and…

Experience

Chief Scientific Officer
Latus Bio
Dec 2022 — Present

Education

University of Michigan Medical School
MD, PhD, Neuroscience
1984 — 1991
Harvard University
A.B., Biology (Neurobiology)
1979 — 1983
Harvard College
A.B, Biology (Neurobiology)
University of Michigan
M.D. and Ph.D, Neuroscience
1984 — 1991

Skills

Pharmacology
Clinical Development
Clinical Research
Neuroscience
Drug Development
Clinical Pharmacology
Biomarkers
Clinical Monitoring
Epigenetics
Biochemistry
Life Sciences
Lifesciences
Oncology
Clinical Trials
Neurology
Huntington's Disease
Animal Models
Disease
Drug Discovery
Alzheimer's Disease
Translational Medicine
Molecular Biology
Psychiatry
Neurodegeneration
Translational Research

Contact information

Verified work emails, personal emails, and direct dials — unlocked in one click.

Work email
•••••@latusbio.com
Personal email
•••••@•••••.com
Direct dial
+•• ••• ••• ••••

Unlock verified contacts

Free to start · No credit card required

Current company

Latus Bio

Biotechnology Research · 28 employees · Founded 2022

At Latus Bio, we are developing novel therapeutics for CNS disorders with our revolutionary AAV capsids. We have developed capsid variants with unprecedented potency, specificity, and trophism. All of our capsids were designed with a particular disease in mind, in order to find the right capsid and the right route of administration to target the most relevant brain regions and cell types for each specific indication. Founded on the groundbreaking work of Professor Beverly Davidson from the Children's Hospital of Philadelphia, Latus Bio is committed to transforming patient care through targeted, potent, and safe gene therapies. We are focused on CNS diseases such as CLN2 (Batten Disease) and Huntington’s Disease, aiming to fundamentally alter the course of these challenging conditions by always putting the patients first. We are not just developing therapies; we are revolutionizing the future of healthcare with innovations that reduce therapeutic load, enhance safety, facilitate manufacturing, and expand access. Latus Bio is powered by a diverse team of visionary scientists, clinicians, and industry leaders dedicated to tackling some of the most complex neurological disorders. With a robust pipeline and a strategy to enter clinical trials by late 2025, we are poised to make significant strides quickly. Be part of this transformative movement at Latus Bio. Let's unlock the potential of gene therapy to bring hope and healing to millions around the globe. Learn more about our mission, our people, and our promise at www.latusbio.com and connect with us on LinkedIn to follow our progress. Any Latus Bio job opportunities will be posted on our website at latusbio.com - Our legitimate email domain is latusbio.com - We are not affiliated with the latusbio.org domain - Latus Bio does not request payment, fees, or sensitive personal or financial information as part of the recruiting process

latusbio.com

Find verified contacts for anyone on LinkedIn

Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.

Start for free See how it works

Free plan included · No credit card required

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

About Jang-Ho Cha

Experience

Chief Scientific Officer

Education

University of Michigan Medical School

Harvard University

Harvard College

University of Michigan

Skills

Find verified contacts for anyone on LinkedIn